These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 9435417

  • 1. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas.
    Blevins LS, Christy JH, Khajavi M, Tindall GT.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):63-7. PubMed ID: 9435417
    [Abstract] [Full Text] [Related]

  • 2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 3. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas.
    Salenave S, Gatta B, Pecheur S, San-Galli F, Visot A, Lasjaunias P, Roger P, Berge J, Young J, Tabarin A, Chanson P.
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3371-6. PubMed ID: 15240617
    [Abstract] [Full Text] [Related]

  • 4. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
    Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
    [Abstract] [Full Text] [Related]

  • 5. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
    Cannavò S, Almoto B, Dall'Asta C, Corsello S, Lovicu RM, De Menis E, Trimarchi F, Ambrosi B.
    Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
    [Abstract] [Full Text] [Related]

  • 6. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.
    Dickerman RD, Oldfield EH.
    J Neurosurg; 2002 Dec; 97(6):1343-9. PubMed ID: 12507132
    [Abstract] [Full Text] [Related]

  • 7. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
    Arvat E, Giordano R, Ramunni J, Arnaldi G, Colao A, Deghenghi R, Lombardi G, Mantero F, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
    [Abstract] [Full Text] [Related]

  • 8. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 9. Repeat transsphenoidal surgery for Cushing's disease.
    Friedman RB, Oldfield EH, Nieman LK, Chrousos GP, Doppman JL, Cutler GB, Loriaux DL.
    J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
    [Abstract] [Full Text] [Related]

  • 10. FSH-producing macroadenoma associated in a patient with Cushing's disease.
    Oyama K, Yamada S, Hukuhara N, Hiramatsu R, Taguchi M, Yazawa M, Matsuda A, Ohmura E, Imai Y.
    Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
    Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB, Savage MO.
    Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
    [Abstract] [Full Text] [Related]

  • 12. Significant gene expression of insulin-like growth factor II and proliferating cell nuclear antigen in a rapidly growing recurrent pituitary acth-secreting adenoma.
    Hashimoto K, Nagano I, Asaba K, Inoue M, Nishioka T, Takao T, Nakajo T, Mori T, Kurisaka M, Otsuka F.
    Horm Res; 2000 Jun; 54(4):198-202. PubMed ID: 11416238
    [Abstract] [Full Text] [Related]

  • 13. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
    Mahler C, Verhelst J, Klaes R, Trouillas J.
    Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
    [Abstract] [Full Text] [Related]

  • 14. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.
    Johnston PC, Kennedy L, Hamrahian AH, Sandouk Z, Bena J, Hatipoglu B, Weil RJ.
    Pituitary; 2017 Aug; 20(4):430-440. PubMed ID: 28265841
    [Abstract] [Full Text] [Related]

  • 15. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E, Maiter D, Grandin C, Raftopoulos C.
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [Abstract] [Full Text] [Related]

  • 16. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
    Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB.
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
    [Abstract] [Full Text] [Related]

  • 17. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG, Frölich M, Pincus SM, Veldhuis JD, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.